AbD Serotec and BBInternational (BBI) will market each other's products as a result of the companies signing a co-marketing agreement.
The agreement will give BBI customers access to more than 13,000 antibodies and immunological reagents, custom monoclonal antibodies developed from the Morphosys Hucal library and large- and small-scale antibody production and conjugation services, all from AbD Serotec.
AbD Serotec antibody customers will have the advantage of direct access to BBI's complementary range of services for production of gold-labelled reagents, contract research-and-development and manufacture of rapid diagnostic tests for point-of-care (POC) markets.
